VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
OXBR
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
OXBROxbridge Re Holdings Limited
$1.47$12M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksOXBRQuarterly Financials

Oxbridge Re Holdings Limited (OXBR) Quarterly Financials

120+ quarters historyFree accessUpdated daily

Oxbridge Re Holdings Limited (OXBR) quarterly income statement — complete revenue, gross profit & net income history

OXBR Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21Q2'21
Revenue623K576K645K664K692K422K205K44K-125K-1.91M-6.38M691K546K1.04M-696K503K-197K2.07M7.03M805K
Revenue Growth %-9.97%36.49%214.63%1409.09%653.6%122.15%103.21%-93.63%-122.89%-283%-816.81%37.38%377.16%-49.73%-109.9%-37.52%-161.76%317.54%2613.9%67.01%
Medical Costs & Claims0510K61K2.36M066K66K62K60K61K60K20K001.14M21K197K23K199K22K
Medical Cost Ratio %0%88.54%9.46%354.97%0%15.64%32.2%140.91%-48%-3.2%-0.94%2.89%0%0%-163.51%4.17%-100%1.11%2.83%2.73%
Gross Profit623K66K584K-1.69M692K356K139K-18K-185K-1.97M-6.44M671K546K1.04M-1.83M482K-394K2.05M6.83M783K
Gross Margin %100%11.46%90.54%-254.97%100%84.36%67.8%-40.91%148%103.2%100.94%97.11%100%100%263.51%95.83%200%98.89%97.17%97.27%
Gross Profit Growth %-9.97%-81.46%320.14%-9305.56%474.05%118.11%102.16%-102.68%-133.88%-288.86%-251.2%39.21%238.58%-49.17%-126.85%-38.44%-231.77%336.67%2843.97%67.67%
Operating Expenses583K531K754K1.26M570K431K432K566K488K475K628K677K404K363K323K389K338K460K280K312K
OpEx / Revenue %93.58%92.19%116.9%189.31%82.37%102.13%210.73%1286.36%-390.4%-24.93%-9.84%97.97%73.99%34.87%-46.41%77.34%-171.57%22.21%3.98%38.76%
Depreciation & Amortization1K1K00001K02K1K2K1K001K02K1K1K2K
Combined Ratio %93.58%180.73%126.36%544.28%82.37%117.77%242.93%1427.27%-438.4%-28.14%-10.78%100.87%73.99%34.87%-209.91%81.51%-271.57%23.32%6.81%41.49%
Operating Income40K-465K-170K-2.95M122K-75K-293K-584K-673K-2.44M-7.07M-6K142K678K-2.16M93K-361K1.59M6.55M471K
Operating Margin %6.42%-80.73%-26.36%-444.28%17.63%-17.77%-142.93%-1327.27%538.4%128.14%110.78%-0.87%26.01%65.13%309.91%18.49%183.25%76.68%93.19%58.51%
Operating Income Growth %-67.21%-520%41.98%-405.14%118.13%96.93%95.86%-9633.33%-573.94%-460.03%-227.72%-106.45%139.34%-57.3%-132.93%-80.25%-868.09%663.46%93671.43%154.59%
EBITDA41K-464K-170K-2.95M122K-75K-292K-584K-671K-2.44M-7.07M-5K142K678K-2.16M93K-359K1.59M6.55M473K
EBITDA Margin %6.58%-80.56%-26.36%-444.28%17.63%-17.77%-142.44%-1327.27%536.8%128.08%110.75%-0.72%26.01%65.13%309.77%18.49%182.23%76.73%93.2%58.76%
Interest Expense00000000000000000000
Non-Operating Income000000000000142K678K0023K000
Pretax Income40K-465K-170K-2.95M122K-75K-293K-584K-673K-2.44M-7.07M-6K142K678K-2.16M93K-361K1.59M6.55M471K
Pretax Margin %6.42%-80.73%-26.36%-444.28%17.63%-17.77%-142.93%-1327.27%538.4%128.14%110.78%-0.87%26.01%65.13%309.91%18.49%183.25%76.68%93.19%58.51%
Income Tax00000000000000000000
Effective Tax Rate %0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%
Net Income24K-569K-185K-2.82M108K-214K-293K-584K-673K-2.44M-7.07M-6K142K678K-2.16M93K-361K1.59M6.55M471K
Net Margin %3.85%-98.78%-28.68%-424.55%15.61%-50.71%-142.93%-1327.27%538.4%128.14%110.78%-0.87%26.01%65.13%309.91%18.49%183.25%76.68%93.19%58.51%
Net Income Growth %-77.78%-165.89%36.86%-382.71%116.05%91.23%95.86%-9633.33%-573.94%-460.03%-227.72%-106.45%139.34%-57.3%-132.93%-80.25%-868.09%663.46%93671.43%154.59%
EPS (Diluted)0.000.02-0.02-0.25-0.02-0.08-0.09-0.14-0.15-0.46-1.20-0.000.020.18-0.370.02-0.060.281.140.08
EPS Growth %113.93%120.88%72.34%-78.57%86.6%83.65%92.65%--719.83%-355.56%-221.65%-106.21%138.53%-35.71%-132.78%-79.88%-833.33%-166.67%
EPS (Basic)0.000.02-0.02-0.25-0.02-0.08-0.09-0.14-0.15-0.46-1.20-0.000.020.18-0.370.02-0.070.281.140.08
Diluted Shares Outstanding7.8M7.39M7.66M7.44M6.9M6.12M6.12M6.01M6.01M5.87M5.87M5.87M5.86M5.78M5.78M5.78M5.75M5.74M5.73M5.73M